
|Articles|June 14, 2020
AstraZeneca's Adrian Kilcoyne Discusses Lung Cancer, Screening (pt.3)
Author(s)Briana Contreras, Peter Wehrwein
Advertisement
Adrian Kilcoyne MD MBA MPH, vice president, US Medical Affairs and HEOR, oncology, AstraZeneca, discusses the process of screening for lung cancer and the populations who are screened. This topic was presented at the American Society of Clinical Oncology's annual conference which was held virtually this year in late May.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Nearly all Ryan White HIV/AIDS Program patients virally suppressed in 2024
2
Risk-based breast cancer screening reliable, preferred by women over annual screening, study shows
3
Shekhar Khera of RxBenefits on the transformative impact of AI in healthcare
4
Detalimogene gene therapy shows promising results in bladder cancer trial
5






















































